Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Patient specific biological responses to total joint replacements
ISRCTN ISRCTN21046383
ClinicalTrials.gov identifier
Public title Patient specific biological responses to total joint replacements
Scientific title
Acronym Patient specific biological responses to total joint replacements
Serial number at source 3298
Study hypothesis This research will be carried out at the University of Leeds and is a collaborative research programme between the Institute of Medical and Biological Engineering and Consultant Orthopaedic Surgeons, Mr Martin Stone (Chapel Allerton) and Mr David Shaw (Bradford Royal Infirmary). Patients will be recruited from two groups, patients awaiting hip replacement operations and patients with long-term polyethylene implants. Approximately 100 patients from each group will be studied.

Patients awaiting hip replacement will have an additional 30 ml of blood collection pre-operatively. Inclusion in the study will not affect patient care in any way, and the surgical procedure will be the same whether the patient chooses to participate in the study or not. Patients with long-term implants will be invited by letter to attend the clinic to volunteer the additional 30 ml blood sample.

The blood samples will be processed by the researchers at the University of Leeds, where the white blood cells will be isolated and used in culture with real wear particles generated by articulation. Cytokine production will be measured by enzyme-linked immunospecific assay (ELISA). Approximately 1 x 10^6 cells will be stored for genetic analysis to determine specific base changes in the DNA. The clinical results of the patients will be followed in follow-up clinics.

The control group will comprise approximately 30 healthy volunteers from the research group (iMBE, Faculty of Biological Sciences & School of Mechanical Engineering). A single 30 ml blood sample will be collected from each control subject by trained personel. Collection of blood samples for research purposes is performed routinely and approval has been awarded from the Faculty of Biological Sciences Research Ethics Committee.
Lay summary
Ethics approval MREC approved (ref: CA03/008)
Study design Single centre non-randomised interventional treatment trial
Countries of recruitment United Kingdom
Disease/condition/study domain Topic: Musculoskeletal; Subtopic: Musculoskeletal (all Subtopics); Disease: Musculoskeletal
Participants - inclusion criteria Patients with a Charnley hip prosthesis that has been in situ for 10 years
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/09/2009
Anticipated end date 30/06/2009
Status of trial Completed
Patient information material
Target number of participants Planned sample size: 200
Interventions In addition to the usual blood tests on addmission, an extra 30 ml volume of blood is required pre-operatively for the research project. The blood will be drawn from a needle already inserted, or to be inserted for routine samples.
Primary outcome measure(s) Cytokine released by primary human macrophages from individual patients in response to 100 cubic micrometers of polyethylene.
Secondary outcome measure(s) 1. Correlation of genotype with clinical outcome of THR surgery
2. Correlation of phenotypic response to cytokine promoter polymorphism genotype
3. Number of patients that are low responders, intermediate responders and aggressive responders to wear particles
Sources of funding Engineering and Physical Sciences Research Council (EPSRC) (UK)
Trial website
Publications
Contact name Mr  MH  Stone
  Address Great George Street
  City/town Leeds
  Zip/Postcode LS1 3EX
  Country United Kingdom
  Email martin.stone@leedsth.nhs.uk
Sponsor University of Leeds (UK)
  Address Woodhouse Lane
  City/town Leeds
  Zip/Postcode LS2 9JT
  Country United Kingdom
  Sponsor website: http://www.leeds.ac.uk/
Date applied 24/06/2010
Last edited 24/06/2010
Date ISRCTN assigned 24/06/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central